High Court Asked To Weigh Inequitable Conduct Ruling
Subsidiaries of Sanofi-Aventis have asked the U.S. Supreme Court to weigh in on a decision that upheld a lower court's finding that Aventis' patents for its anti-clotting drug Lovenox were invalid...To view the full article, register now.
Already a subscriber? Click here to view full article